Titan Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 418.34 million compared to INR 420.07 million a year ago. Revenue was INR 426.9 million compared to INR 422.64 million a year ago. Net income was INR 91.27 million compared to INR 63.92 million a year ago. Basic earnings per share from continuing operations was INR 11.04 compared to INR 7.74 a year ago. Diluted earnings per share from continuing operations was INR 11.04 compared to INR 7.74 a year ago.
For the six months, sales was INR 768.3 million compared to INR 834.47 million a year ago. Revenue was INR 780.03 million compared to INR 838.47 million a year ago. Net income was INR 166.31 million compared to INR 151.16 million a year ago. Basic earnings per share from continuing operations was INR 20.13 compared to INR 18.29 a year ago. Diluted earnings per share from continuing operations was INR 20.13 compared to INR 18.29 a year ago.